ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accomodation

Liver Transplantation

Volumn 9, Issue 1, 2003, Pages 22-30

  Hanto, Douglas W ^a,b   Fecteau, Annie H ^a,c   Alonso, Maria H ^a,d   Valente, John F ^a,e   Whiting, James F ^a,f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBODY; ANTIFUNGAL AGENT; CEFOTETAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUCONAZOLE; GANCICLOVIR; HEMAGGLUTININ; IMMUNOGLOBULIN G; MEPREDNISONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PNEUMOCOCCUS VACCINE; PREDNISONE; STEROID; SULTAMICILLIN; TACROLIMUS;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BILE DUCT DISEASE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; BLOOD GROUP O; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SENSITIVITY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NOCARDIA; PLASMAPHERESIS; PNEUMOCYSTIS; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SPLENECTOMY; TIME; VASCULAR DISEASE;

EID: 0037235105     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50011     Document Type: Article

References (39)

1. Kissmeyer-Nielsen F, Olsen S, Petersen VT, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966;2: 662-665.
2. Carpenter CB, D'Apice AJF, Abbas AK. The role of antibodies in the rejection and enhancement of organ allografts. Adv Immunol 1976;22:1-65.
3. Paul LC, Baldwin WM III. Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transplant Proc 1987;19:4463-4467.
4. Cooper DKC. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 1990;9:376-381.
5. 2 antibodies. Transplantation 1993;56: 1581-1583.
6. Slapak M, Naik RB, Lee HA. Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation 1981;31:4-7.
7. Alexandre GPJ, Squifflet JP, DeBruyere M, Latinne M, Moriau M, Ikalou N, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985;17:138-143.
8. Bannett AD, McAlack RF, Baquero A, Morris M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987;19:4543-4546.
9. Bannett AD, Bensinger WI, Raja R, Baquero A, McAlack RF. Immunoadsorption and renal transplant in two patients with a major ABO incompatibility. Transplantation 1987;43:909-911.
10. Alexandre GPJ, Squifflet JP, De Bruyere M, Latinne D, Reding R, Gianello P, et al. Present experience in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538-4540.
11. Rieben R, Korchagina Ey, von Allmen E, Hovinga J, Lammle B, Jungi T, et al. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 1995;60:425-430.
12. Hanto DW, Snover DC, Sibley RK, Noreen HJ, Gajl-Pezalska KJ, Najarian JS, Ascher NL. Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient. Clin Transplantation 1987;1:304-310.
13. Starzl TE, Demetris AJ, Todo S, Kang Y, Tzakis A, Duquesnoy R, et al. Evidence for hyperacute rejection of liver grafts: The case of the canary kidneys. Clin Transplantation 1989;3:37-45.
14. Ratner LE, Phelan D, Brunt EM, Mohannakumar T, Hanto DW. Probable antibody-mediated failure of two sequential ABO compatible hepatic allografts in a single recipient. Transplantation 1993;55:814-819.
15. Demetris AJ, Jaffe R, Tzakis A, Ramseg G, Todo S, Belle S, et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988;132:489-502.
16. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990;336: 519-523.
17. Reding R, Veyckemans F, De Ville de Goyet J, de Hemptinne B, Carlier M, Van Obbergh L, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet 1992;174:59-64.
18. Gordon RD, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE, et al. Liver transplantation across ABO blood groups. Surgery 1986;100:342-348.
19. Farges O, Nocci Kalil A, Samuel D, Arulnaden JL, Bismuth A, Castaing D, Bismuth H. Long-term results of ABO-incompatible liver transplantation. Transplant Proc 1995;27:1701-1702.
20. Farges O, Nocci Kalil A, Samuel D, Saliba F, Arulnaden JL, Debar P, et al. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients. Transplantation 1995;59:1124-1133.
21. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz M, Emre S, et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995;59:986-990.
22. Ishida H, Koyama I, Sawada T, Utsumi K, Murakami T, Sannomiya A, et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: Survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 2000;70: 681-685.
23. West LJ, Pollock-Barziv SM, Dipchand AI, Lee KJ, Cardella CJ, Benson LN, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793-800.
24. Choi AKK, Ling J, McCaughan GW, Painter D, Shun A, Dorney SFA, et al. ABO blood group incompatibility in liver transplantation: A single center experience. Aust N Z J Surg 1997;67: 275-278.
25. Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, et al. Long-term results of ABO-incompatible living kidney transplantation. Transplantation 1998;65:224-228,
26. Neumann UP, Lang M, Moldenhauer A, Langrehr JM, Glanemann M, Kahl A, et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation, Transplantation 2001;71:1163-1168.
27. Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host TH2 cytokine environment. Nat Med 1997;3:196-204.
28. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 1997;18:483-486.
29. Hechenleitner P, Mark W, Candinas D, Miyatake T, Koyamada N, Hancock WW, Bach FH. Protective genes expressed in endothelial cells of second hamster heart transplants to rats carrying an accommodated first graft. Xenotransplantation 1996;3:279-286.
30. Bach FH, Stuhlmeier KM, Vanhove B, Van der Werf WJ, Blakely ML, de Martin R, et al. Endothelial cells in xenotransplantation: do they accommodate? Transplant Proc 1994;26: 1167-1169.
31. Winkler H, Ferran C, Bach FH. Accommodation of xenografts: A concept revisited. Xenotransplantation 1996;2:53-56.
32. Nelson PW, Landreneau MD, Luger AM, Pierce GE, Ross G, Shield CF, et al. Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998;65:256-260.
33. Alkhunaizi AM, de Mattos AM, Barry JM, Bennett WM, Norman DJ. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999;67:1319-1324.
34. Renard TH, Andrews WS. An approach to ABO-incompatible liver transplantation in children. Transplantation 1992;53:116-121.
35. Tokunaga Y, Tanaka K, Fujita S, Yamaguchi T, Sawada H, Kato H, et al. Living related liver transplantation across ABO blood groups with FK506 and OKT3. Transplant Int 1993;6:313-318.
36. Yandza Y, Lambert T, Alvarez F, Gauthier F, Jacolot D, Huault G, et al. Outcome of ABO-incompatible liver transplantation in children with no specific alloantibodies at the time of transplantation. Transplantation 1994;58:46-50.
37. Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993;136:5-28.
38. Hanto DW, Whiting JF, Valente JF. Transplantation of the liver and intestine. In: Norton JA, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, Thompson RW, eds. Surgery: Scientific Basis and Current Practice. New York: Springer-Verlag; 2000: 1473-1508.
39. Whiting JF, Fecteau AF, Martin J, Bejarano PA, Hanto DW. Use of low dose OKT3 as induction therapy in liver transplantation. Transplantation 1998;65:577-580.